Search
for
Sort by
Research 61–90 of 74
- An Investigation of Hair and its Keratin Associated Proteins using Advanced Light Microscopy
- Selective Sensing of Darolutamide and Thalidomide in Pharmaceutical Preparations and in Spiked Biofluids
- Investigation of hair dye deposition, hair color loss, and hair damage during multiple oxidative dyeing and shampooing cycles.
- An improved synthesis of finasteride from 4-androsten-3,17-dione
- Discovery of Nonsteroidal Androgens
- FORMULATION AND EVALUATION OF HERBAL SHAMPOO
- Anti-Androgen Drugs in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
- Recent advances in highly-efficient near infrared OLED emitters
- Antiexudative Effects of Finasteride and a New Pyrazolo[C]Pyridine Derivative GIZh-72 in Acetic Acid-Induced Experimental Peritonitis
- Synthesis, Characterisation, andIn VitroAnticancer Activity of Curcumin Analogues Bearing Pyrazole/Pyrimidine Ring Targeting EGFR Tyrosine Kinase
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Efficacy and safety of omeprazole for severe gastroesophageal reflux in children
- Alopecia Areata: Current Treatments and New Directions
- Effects of Camellia oleifera seed shell polyphenols and 1,3,6-tri-O-galloylglucose on androgenic alopecia via inhibiting 5a-reductase and regulating Wnt/β-catenin pathway
- Advancing mitochondrial therapeutics: Synthesis and pharmacological evaluation of pyrazole-based inhibitors targeting the mitochondrial pyruvate carrier
- Preparation, Characterization and Molecular Docking Study of some New Pyrazole Derivatives Derived from 2-Mercaptobenzothiazole.
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Enzymes
- In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
- Cutaneous drug reactions
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Steroid Hormones
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Evaluation of Olive Oil-Based Formulations Loaded with Baricitinib for Topical Treatment of Alopecia Areata
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro